Inventor
STROP PAVEL
US29 patents
⚠️ This page may combine multiple inventors who share the name “STROP PAVEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
12 patentsUS9969809B2May 15, 2018
Therapeutic antibodies and their uses
PFIZER44 citations96
US8828401B2Sep 9, 2014
Cytotoxic peptides and antibody drug conjugates thereof
PFIZER35 citations92
US11814435B2Nov 14, 2023
Therapeutic antibodies and their uses
PFIZER5 citations84
US10793635B2Oct 6, 2020
Therapeutic antibodies and their uses
PFIZER4 citations83
US10040860B2Aug 7, 2018
Therapeutic antibodies and their uses
PFIZER6 citations83
US9249186B2Feb 2, 2016
Cytotoxic peptides and antibody drug conjugates thereof
PFIZER7 citations82
US9138486B2Sep 22, 2015
Cytotoxic peptides and antibody drug conjugates thereof
PFIZER7 citations82
US11155630B2Oct 26, 2021
Therapeutic antibodies and their uses
PFIZER3 citations72
US10689458B2Jun 23, 2020
Site specific HER2 antibody drug conjugates
PFIZER3 citations69
US10941216B2Mar 9, 2021
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
PFIZER0 citations62
US11993625B2May 28, 2024
Calicheamicin derivatives and antibody drug conjugates thereof
PFIZER1 citations56
US10967068B2Apr 6, 2021
Stability-modulating linkers for use with antibody drug conjugates
PFIZER0 citations49
RINAT NEUROSCIENCE CORP
11 patentsUS8871908B2Oct 28, 2014
Antibodies specific for Trop-2 and their uses
RINAT NEUROSCIENCE CORP86 citations96
US10138303B2Nov 27, 2018
Heterodimeric proteins and methods for producing and purifying them
RINAT NEUROSCIENCE CORP14 citations92
US9399074B2Jul 26, 2016
Antibodies specific for trop-2 and their uses
RINAT NEUROSCIENCE CORP19 citations91
US9175093B2Nov 3, 2015
PCSK9 antagonists
RINAT NEUROSCIENCE CORP6 citations83
US10842881B2Nov 24, 2020
Engineered polypeptide conjugates using transglutaminase
RINAT NEUROSCIENCE CORP2 citations67
US10195289B2Feb 5, 2019
Engineered polypeptide conjugates using transglutaminase
RINAT NEUROSCIENCE CORP3 citations67
US11602525B2Mar 14, 2023
Antibody-drug conjugates with high drug loading
RINAT NEUROSCIENCE CORP2 citations66
US8715673B2May 6, 2014
Staphylococcus aureus specific antibodies and uses thereof
RINAT NEUROSCIENCE CORP4 citations66
US11390689B2Jul 19, 2022
Heterodimeric proteins and methods for producing and purifying them
RINAT NEUROSCIENCE CORP1 citations62
US11091544B2Aug 17, 2021
Antibodies specific for Trop-2 and their uses
RINAT NEUROSCIENCE CORP0 citations61
US10100114B2Oct 16, 2018
Antibodies specific for TROP-2 and their uses
RINAT NEUROSCIENCE CORP1 citations61
BRISTOL MYERS SQUIBB CO
4 patentsUS11242393B2Feb 8, 2022
Antibodies against MICA and/or MICB and uses thereof
BRISTOL MYERS SQUIBB CO3 citations67
US12478674B2Nov 25, 2025
Ipilimumab variants with enhanced specificity for binding at low pH
BRISTOL MYERS SQUIBB CO1 citations59
US12290570B2May 6, 2025
Antibody comprising a glutamine-containing light chain C-terminal extension, conjugates thereof, and methods and uses
BRISTOL MYERS SQUIBB CO0 citations56
US12478686B2Nov 25, 2025
Antibodies modified for transglutaminase conjugation, conjugates thereof, and methods and uses
BRISTOL MYERS SQUIBB CO0 citations44